Lexaria Bioscience (LEXXW) Stock Chart & Stock Price History $0.14 -0.01 (-9.69%) As of 07/11/2025 03:20 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Lexaria Bioscience Stock Price Performance The Lexaria Bioscience (LEXXW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 86.61%, with a year-to-date return of -82.31%. In the past month, the stock has decreased 38.52%, reflecting recent market activity. As of the latest close, Lexaria Bioscience traded at $0.14 with a market cap of and volume of 869 shares. Receive LEXXW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-9.69%1 Month Performance-38.52%3 Month Performance-62.44%Year-To-Date Performance-82.31%1 Year Performance-86.61% LEXXW Stock Chart for Monday, July, 14, 2025 LEXXW Chart by TradingView Lexaria Bioscience Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$0.15$0.14-9.69%$0.15$0.14869 shs$0.0007/10/2025$0.15$0.15$0.15$0.15600 shs$0.0007/09/2025$0.15$0.15-0.20%$0.15$0.15666 shs$0.0007/08/2025$0.15$0.15$0.16$0.153,300 shs$0.0007/07/2025$0.15$0.15$0.16$0.153,332 shs$0.0007/04/2025$0.15$0.15$0.15$0.152,411 shs$0.0007/03/2025$0.15$0.15+2.04%$0.15$0.152,411 shs$0.0007/02/2025$0.18$0.15-18.33%$0.18$0.112,400 shs$0.0007/01/2025$0.10$0.18+80.00%$0.18$0.151,750 shs$0.0006/30/2025$0.11$0.10-9.09%$0.13$0.0738,131 shs$0.00 Get the Latest News and Ratings for LEXXW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$0.15$0.11-26.67%$0.11$0.11200 shs$0.0006/26/2025$0.15$0.15$0.17$0.1514,900 shs$0.0006/25/2025$0.15$0.15$0.17$0.1514,920 shs$0.0006/24/2025$0.22$0.15-31.79%$0.17$0.1514,920 shs$0.0006/23/2025$0.22$0.22$0.22$0.161,800 shs$0.0006/20/2025$0.22$0.22$0.22$0.161,800 shs$0.0006/18/2025$0.22$0.22$0.22$0.161,800 shs$0.0006/17/2025$0.22$0.220.00%$0.22$0.161,800 shs$0.0006/16/2025$0.22$0.22$0.22$0.161,810 shs$0.0006/13/2025$0.23$0.22-4.39%$0.22$0.161,810 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Ainos Stock Price Chart Alvotech Stock Price Chart ARAVIVE Stock Price Chart Atlantic Coastal Acquisition Corp. II Stock Price Chart Biofrontera Stock Price Chart biote Stock Price Chart BriaCell Therapeutics Stock Price Chart Receive LEXXW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LEXXW) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredDid you miss out on Trump’s “birthday gift” to Americans?While protestors were rallying against “King Trump,” one trader quietly spotted a 15% weekend move tied to his...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LEXXW Stock Alerts